The syndrome of synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) is a rare condition characterized by a combination of osteo-articular and cutaneous manifestations. Hallmark of the disease is the presence of osteitic/hyperostotic lesions involving osteo-articular structures of the anterior chest wall (ACW). Emerging evidence suggests that SAPHO might be a primitive osteitis, probably related to polygenic autoinflammatory disorders. The rarity of the disease and its unknown aetio-pathogenesis make targeted therapy unavailable. In this report we describe for the first time effective treatment of SAPHO syndrome with the interleukin-1 receptor antagonist (IL-1Ra) anakinra.
File in questo prodotto:
Non ci sono file associati a questo prodotto.